144 related articles for article (PubMed ID: 6882706)
1. Vasopressin effects on isolated non-pregnant myometrium and uterine arteries and their inhibition by deamino-ethyl-lysine-vasopressin and deamino-ethyl-oxytocin.
Akerlund M; Kostrzewska A; Laudănski T; Melin P; Vilhardt H
Br J Obstet Gynaecol; 1983 Aug; 90(8):732-8. PubMed ID: 6882706
[TBL] [Abstract][Full Text] [Related]
2. Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonist.
Hauksson A; Akerlund M; Melin P
Br J Obstet Gynaecol; 1988 Sep; 95(9):898-904. PubMed ID: 3191063
[TBL] [Abstract][Full Text] [Related]
3. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin.
Akerlund M; Carlsson AM; Melin P; Trojnar J
Acta Obstet Gynecol Scand; 1985; 64(6):499-504. PubMed ID: 4061066
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vasopressin effects on the uterus by a synthetic analogue.
Akerlund M; Strömberg P; Forsling ML; Melin P; Vilhardt H
Obstet Gynecol; 1983 Sep; 62(3):309-12. PubMed ID: 6877687
[TBL] [Abstract][Full Text] [Related]
5. Vasotocin analogues which competitively inhibit vasopressin stimulated uterine activity in healthy women.
Akerlund M; Hauksson A; Lundin S; Melin P; Trojnar J
Br J Obstet Gynaecol; 1986 Jan; 93(1):22-7. PubMed ID: 3942702
[TBL] [Abstract][Full Text] [Related]
6. Lysine vasopressin-induced increases in porcine myometrial contractility and intracellular Ca2+ concentrations of myometrial cells: involvement of oxytocin receptors.
Yu H; Zhuge R; Hsu WH
Biol Reprod; 1995 Mar; 52(3):584-590. PubMed ID: 7756452
[TBL] [Abstract][Full Text] [Related]
7. Interaction of vasopressin and prostaglandins in the nonpregnant human uterus.
Laudański T; Kostrzewska A; Akerlund M
Prostaglandins; 1984 Mar; 27(3):441-52. PubMed ID: 6587440
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity.
Melin P; Vilhardt H; Lindeberg G; Larsson LE; Akerlund M
J Endocrinol; 1981 Feb; 88(2):173-80. PubMed ID: 7193709
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of angiotensin, vasopressin and oxytocin on various smooth muscle tissues within the human uteroplacental unit.
Maigaard S; Forman A; Andersson KE
Acta Physiol Scand; 1986 Sep; 128(1):23-31. PubMed ID: 3766172
[TBL] [Abstract][Full Text] [Related]
10. Oxytocin and vasopressin constrict rat isolated uterine resistance arteries by activating vasopressin V1A receptors.
Chen YL; Shepherd C; Spinelli W; Lai FM
Eur J Pharmacol; 1999 Jul; 376(1-2):45-51. PubMed ID: 10440088
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of nitrendipine on myometrial and vascular smooth muscle in human pregnant uterus and placenta.
Maigaard S; Forman A; Brogaard-Hansen KP; Andersson KE
Acta Pharmacol Toxicol (Copenh); 1986 Jul; 59(1):1-10. PubMed ID: 3464159
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated uterine effects of vasopressin and oxytocin in nonpregnant women.
Bossmar T; Akerlund M; Szamatowicz J; Laudanski T; Fantoni G; Maggi M
Br J Obstet Gynaecol; 1995 Nov; 102(11):907-12. PubMed ID: 8534628
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
Conklin DJ; Smith MP; Olson KR
Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
[TBL] [Abstract][Full Text] [Related]
14. Synthetic antagonists of the myometrial response to vasopressin and oxytocin.
Melin P; Trojnar J; Johansson B; Vilhardt H; Akerlund M
J Endocrinol; 1986 Oct; 111(1):125-31. PubMed ID: 3783079
[TBL] [Abstract][Full Text] [Related]
15. Uterine effects of N-alpha-triglycyl-(8-lysine)-vasopressin and 8-lysine-vasopressin in the first trimester of pregnancy.
Laudański T; Akerlund M
Contraception; 1980 Aug; 22(2):199-208. PubMed ID: 7449382
[TBL] [Abstract][Full Text] [Related]
16. Effect of ovarian steroids and diethylstilbestrol on the contractile responses of the human myometrium and intramyometrial arteries.
Kostrzewska A; Laudánski T; Batra S
Eur J Pharmacol; 1993 Mar; 233(1):127-34. PubMed ID: 8472741
[TBL] [Abstract][Full Text] [Related]
17. SK&F 105494, a V2-vasopressin receptor antagonist, blocks oxytocin receptors in porcine myometrium.
Yu H; Hsu WH
Zhongguo Yao Li Xue Bao; 1996 Jul; 17(4):365-8. PubMed ID: 9812726
[TBL] [Abstract][Full Text] [Related]
18. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea.
Akerlund M; Melin P; Maggi M
Adv Exp Med Biol; 1995; 395():595-600. PubMed ID: 8714023
[TBL] [Abstract][Full Text] [Related]
19. Adaptation to pregnancy leads to attenuated rat uterine artery smooth muscle sensitivity to oxytocin.
Vedernikov YP; Betancourt A; Wentz MJ; Saade GR; Garfield RE
Am J Obstet Gynecol; 2006 Jan; 194(1):252-60. PubMed ID: 16389040
[TBL] [Abstract][Full Text] [Related]
20. Effects of human relaxin on isolated rat and human myometrium and uteroplacental arteries.
Petersen LK; Svane D; Uldbjerg N; Forman A
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):757-62. PubMed ID: 1923192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
